About INC Research Holdings (NASDAQ:INCR)
INC Research Holdings, Inc. is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company's Clinical Development Services segment offers a range of clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Research Services
- Sub-Industry: N/A
- Symbol: NASDAQ:INCR
- CUSIP: N/A
- Web: www.incresearch.com
Capitalization:- Market Cap: $3.04 billion
- Outstanding Shares: 54,103,000
Average Prices:- 50 Day Moving Avg: $46.48
- 200 Day Moving Avg: $49.00
- 52 Week Range: $36.70 - $57.25
P/E:- Trailing P/E Ratio: 26.74
- Foreward P/E Ratio: 18.55
- P/E Growth: 1.51
Sales & Book Value:- Annual Revenue: $1.03 billion
- Price / Sales: 2.95
- Book Value: $6.20 per share
- Price / Book: 9.06
Profitability:- EBIDTA: $230.43 million
- Net Margins: 6.58%
- Return on Equity: 49.42%
- Return on Assets: 10.21%
Debt:- Debt-to-Equity Ratio: 1.78%
- Current Ratio: 1.01%
- Quick Ratio: 1.01%
Misc:- Average Volume: 1.34 million shs.
- Beta: 1.74
- Short Ratio: 1.39
Frequently Asked Questions for INC Research Holdings (NASDAQ:INCR)
What is INC Research Holdings' stock symbol?
INC Research Holdings trades on the NASDAQ under the ticker symbol "INCR."
How were INC Research Holdings' earnings last quarter?
INC Research Holdings Inc (NASDAQ:INCR) posted its quarterly earnings data on Wednesday, May, 10th. The company reported $0.60 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.55 by $0.05. The company had revenue of $252.10 million for the quarter, compared to analyst estimates of $250.76 million. INC Research Holdings had a net margin of 6.58% and a return on equity of 49.42%. The firm's revenue for the quarter was up 1.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.58 EPS. View INC Research Holdings' Earnings History.
What guidance has INC Research Holdings issued on next quarter's earnings?
INC Research Holdings updated its FY17 earnings guidance on Wednesday, May, 10th. The company provided earnings per share (EPS) guidance of $2.66-2.74 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.66. The company issued revenue guidance of $1.04-1.07 billion, compared to the consensus revenue estimate of $1.06 billion.
Where is INC Research Holdings' stock going? Where will INC Research Holdings' stock price be in 2017?
8 equities research analysts have issued twelve-month price objectives for INC Research Holdings' stock. Their predictions range from $48.00 to $66.00. On average, they anticipate INC Research Holdings' stock price to reach $54.33 in the next twelve months. View Analyst Ratings for INC Research Holdings.
Are investors shorting INC Research Holdings?
INC Research Holdings saw a increase in short interest in April. As of April 28th, there was short interest totalling 3,665,932 shares, an increase of 4.7% from the April 13th total of 3,502,456 shares. Based on an average daily trading volume, of 801,902 shares, the short-interest ratio is presently 4.6 days.
Who are some of INC Research Holdings' key competitors?
Some companies that are related to INC Research Holdings include DexCom (DXCM), ABIOMED (ABMD), Bioverativ (BIVV), Exelixis (EXEL), William Demant Hol (WILYY), Ionis Pharmaceuticals (IONS), United Therapeutics (UTHR), athenahealth (ATHN), MEDNAX (MD), Hill-Rom Holdings (HRC), Icon Plc (ICLR), Neurocrine Biosciences (NBIX), Valeant Pharmaceuticals Intl (VRX), PRA Health Sciences (PRAH), Masimo (MASI), VWR Corp (VWR), Charles River Laboratories Intl. (CRL) and Catalent (CTLT).
Who owns INC Research Holdings stock?
INC Research Holdings' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.19%), BlackRock Inc. (6.56%), Acadian Asset Management LLC (2.47%), Mackenzie Financial Corp (2.22%), TimesSquare Capital Management LLC (1.74%) and Jennison Associates LLC (1.61%). Company insiders that own INC Research Holdings stock include Alistair Macdonald, Avista Capital Partners Ii Gp,, Christopher L Gaenzle, D Jamie Macdonald, David F Burgstahler, Gregory S Rush, James T Ogle, Michael Gibertini, Robert W Breckon and Teachers Pension Plan Ontario. View Institutional Ownership Trends for INC Research Holdings.
Who sold INC Research Holdings stock? Who is selling INC Research Holdings stock?
INC Research Holdings' stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Jennison Associates LLC, Tudor Investment Corp ET AL, Russell Investments Group Ltd., AMI Asset Management Corp, Wells Fargo & Company MN, Renaissance Technologies LLC and Underhill Investment Management LLC. Company insiders that have sold INC Research Holdings stock in the last year include Alistair Macdonald, Avista Capital Partners Ii Gp,, Christopher L Gaenzle, D Jamie Macdonald, Gregory S Rush, Michael Gibertini, Robert W Breckon and Teachers Pension Plan Ontario. View Insider Buying and Selling for INC Research Holdings.
Who bought INC Research Holdings stock? Who is buying INC Research Holdings stock?
INC Research Holdings' stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., MARSHALL WACE ASIA Ltd, Marshall Wace North America L.P., Redmile Group LLC, Mackenzie Financial Corp, Point72 Asset Management L.P., Wellington Management Group LLP and Goldman Sachs Group Inc.. View Insider Buying and Selling for INC Research Holdings.
How do I buy INC Research Holdings stock?
Shares of INC Research Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of INC Research Holdings stock cost?
One share of INC Research Holdings stock can currently be purchased for approximately $56.20.
Earnings History for INC Research Holdings (NASDAQ:INCR)Earnings History by Quarter for INC Research Holdings (NASDAQ:INCR)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/10/2017 | Q1 2017 | $0.55 | $0.60 | $250.76 million | $252.10 million | View | N/A |  |
| 2/28/2017 | Q4 2016 | $0.67 | $0.67 | $269.00 million | $263.00 million | View | Listen | |
| 10/31/2016 | Q316 | $0.59 | $0.64 | $259.89 million | $259.56 million | View | Listen | |
| 7/27/2016 | Q216 | $0.58 | $0.61 | $252.39 million | $258.80 million | View | Listen | |
| 5/2/2016 | Q116 | $0.53 | $0.58 | $237.78 million | $249.00 million | View | Listen | |
| 2/25/2016 | Q415 | $0.49 | $0.54 | $239.31 million | $241.40 million | View | Listen | |
| 10/29/2015 | Q3 | $0.44 | $0.58 | $230.60 million | $234.50 million | View | Listen | |
| 7/30/2015 | Q215 | $0.34 | $0.47 | $219.08 million | $227.40 million | View | Listen | |
| 4/27/2015 | Q115 | $0.26 | $0.41 | $211.20 million | $308.90 million | View | Listen | |
| 2/24/2015 | Q414 | $0.21 | $0.24 | $207.88 million | $213.70 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for INC Research Holdings (NASDAQ:INCR)2017 EPS Consensus Estimate: $2.66
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | $0.56 | $0.64 | $0.61 |
| Q2 2017 | 3 | $0.62 | $0.68 | $0.65 |
| Q3 2017 | 3 | $0.64 | $0.70 | $0.68 |
| Q4 2017 | 4 | $0.68 | $0.75 | $0.72 |
(Data provided by Zacks Investment Research)
Dividend History for INC Research Holdings (NASDAQ:INCR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for INC Research Holdings (NASDAQ:INCR)Insider Ownership Percentage: 1.70%
Institutional Ownership Percentage: 99.79%
Insider Trades by Quarter for INC Research Holdings (NASDAQ:INCR)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/1/2017 | Alistair Macdonald | CEO | Sell | 9,467 | $45.00 | $426,015.00 | |
| 4/3/2017 | Christopher L Gaenzle | CAO | Sell | 4,733 | $45.70 | $216,298.10 | |
| 3/3/2017 | Alistair Macdonald | CEO | Sell | 8,828 | $45.00 | $397,260.00 | |
| 1/20/2017 | Alistair Macdonald | CEO | Sell | 1,375 | $50.50 | $69,437.50 | |
| 1/20/2017 | Christopher L Gaenzle | CAO | Sell | 1,186 | $50.09 | $59,406.74 | |
| 1/19/2017 | Gregory S Rush | VP | Sell | 2,907 | $50.57 | $147,006.99 | |
| 1/5/2017 | Alistair Macdonald | CEO | Sell | 14,840 | $52.19 | $774,499.60 | |
| 9/30/2016 | Gregory S Rush | VP | Sell | 35,503 | $44.70 | $1,586,984.10 | |
| 9/27/2016 | D. Jamie Macdonald | CEO | Sell | 53,970 | $44.30 | $2,390,871.00 | |
| 9/26/2016 | Robert W Breckon | Director | Sell | 12,197 | $44.16 | $538,619.52 | |
| 9/19/2016 | David F Burgstahler | Director | Buy | 1,000 | $43.19 | $43,190.00 | |
| 9/14/2016 | Christopher L Gaenzle | CAO | Sell | 4,734 | $43.14 | $204,224.76 | |
| 8/17/2016 | Alistair Macdonald | COO | Sell | 8,828 | $43.80 | $386,666.40 | |
| 8/4/2016 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 2,554,409 | $42.06 | $107,438,442.54 | |
| 8/4/2016 | Teachers Pension Plan Ontario | Director | Sell | 2,445,591 | $42.06 | $102,861,557.46 | |
| 8/2/2016 | D. Jamie Macdonald | CEO | Sell | 31,279 | $43.00 | $1,344,997.00 | |
| 8/1/2016 | Robert W Breckon | Director | Sell | 108 | $42.00 | $4,536.00 | |
| 7/28/2016 | Gregory S Rush | VP | Sell | 4,066 | $45.23 | $183,905.18 | |
| 7/20/2016 | D. Jamie Macdonald | CEO | Sell | 100,593 | $43.00 | $4,325,499.00 | |
| 7/15/2016 | Gregory S Rush | CFO | Sell | 5,917 | $41.50 | $245,555.50 | |
| 7/11/2016 | Alistair Macdonald | COO | Sell | 9,468 | $40.19 | $380,518.92 | |
| 7/11/2016 | Christopher L Gaenzle | CAO | Sell | 21,918 | $40.20 | $881,103.60 | |
| 7/1/2016 | Gregory S Rush | CFO | Sell | 1,358 | $37.97 | $51,563.26 | |
| 7/1/2016 | Robert W Breckon | Director | Sell | 421 | $37.97 | $15,985.37 | |
| 6/15/2016 | Christopher L Gaenzle | CAO | Sell | 7,702 | $40.14 | $309,158.28 | |
| 6/6/2016 | Michael Gibertini | Insider | Sell | 213,966 | $43.11 | $9,224,074.26 | |
| 6/2/2016 | Robert W Breckon | Director | Sell | 11,691 | $43.53 | $508,909.23 | |
| 5/6/2016 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 4,087,054 | $45.12 | $184,407,876.48 | |
| 5/6/2016 | Teachers Pension Plan Ontario | Director | Sell | 3,912,946 | $45.12 | $176,552,123.52 | |
| 4/18/2016 | James T Ogle | Director | Sell | 114,806 | $50.00 | $5,740,300.00 | |
| 4/12/2016 | D. Jamie Macdonald | CEO | Sell | 94,675 | $48.00 | $4,544,400.00 | |
| 4/1/2016 | Michael Gibertini | Insider | Sell | 9,000 | $40.78 | $367,020.00 | |
| 3/1/2016 | Michael Gibertini | Insider | Sell | 9,000 | $39.85 | $358,650.00 | |
| 2/4/2016 | Robert W. Breckon | Director | Sell | 3,882 | $40.03 | $155,396.46 | |
| 2/1/2016 | Gregory S. Rush | CFO | Sell | 17,752 | $40.27 | $714,873.04 | |
| 2/1/2016 | Michael Gibertini | insider | Sell | 9,000 | $40.57 | $365,130.00 | |
| 1/4/2016 | Michael Gibertini | insider | Sell | 9,000 | $46.83 | $421,470.00 | |
| 12/31/2015 | Alistair Macdonald | COO | Sell | 159,599 | $47.46 | $7,574,568.54 | |
| 12/31/2015 | Christopher L. Gaenzle | CAO | Sell | 9,468 | $48.18 | $456,168.24 | |
| 12/31/2015 | Gregory S. Rush | CFO | Sell | 35,503 | $48.17 | $1,710,179.51 | |
| 12/29/2015 | James T. Ogle | Director | Sell | 9,717 | $50.06 | $486,433.02 | |
| 12/8/2015 | Christopher L. Gaenzle | CAO | Sell | 25,185 | $41.78 | $1,052,229.30 | |
| 12/8/2015 | Gregory S. Rush | CFO | Sell | 81,035 | $45.13 | $3,657,109.55 | |
| 12/7/2015 | Alistair Macdonald | COO | Sell | 42,959 | $44.63 | $1,917,260.17 | |
| 12/7/2015 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 4,597,937 | $45.00 | $206,907,165.00 | |
| 12/7/2015 | Teachers Pension Plan Ontario | Director | Sell | 4,402,063 | $45.00 | $198,092,835.00 | |
| 12/1/2015 | Michael Gibertini | insider | Sell | 9,000 | $46.52 | $418,680.00 | |
| 11/2/2015 | Michael Gibertini | insider | Sell | 9,000 | $41.70 | $375,300.00 | |
| 9/28/2015 | Alistair Macdonald | COO | Sell | 44,522 | $39.93 | $1,777,763.46 | |
| 9/14/2015 | Gregory S. Rush | CFO | Sell | 32,426 | $45.06 | $1,461,115.56 | |
| 8/31/2015 | Christopher L. Gaenzle | CAO | Sell | 17,421 | $41.16 | $717,048.36 | |
| 8/31/2015 | James T Ogle | Director | Sell | 55,000 | $41.12 | $2,261,600.00 | |
| 8/17/2015 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 4,029,168 | $44.00 | $177,283,392.00 | |
| 8/17/2015 | Teachers Pension Plan Ontario | Director | Sell | 3,857,525 | $44.00 | $169,731,100.00 | |
| 8/12/2015 | D. Jamie Macdonald | CEO | Sell | 57,021 | $44.00 | $2,508,924.00 | |
| 8/12/2015 | Robert W Breckon | Director | Sell | 8,381 | $44.00 | $368,764.00 | |
| 5/14/2015 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 6,599,761 | $29.68 | $195,880,906.48 | |
| 5/14/2015 | Teachers Pension Plan Ontario | Director | Sell | 6,318,607 | $29.68 | $187,536,255.76 | |
| 5/7/2015 | Gregory S Rush | CFO | Sell | 12,455 | $29.68 | $369,664.40 | |
| 5/7/2015 | Michael Gibertini | Insider | Sell | 50,000 | $29.68 | $1,484,000.00 | |
| 5/7/2015 | Robert W Breckon | Director | Sell | 8,226 | $29.68 | $244,147.68 | |
(Data available from 1/1/2013 forward)
Headline Trends for INC Research Holdings (NASDAQ:INCR)
Latest Headlines for INC Research Holdings (NASDAQ:INCR)
| Source: |
|
| Date | Headline |
|---|
 | ETFs with exposure to INC Research Holdings, Inc. : May 22, 2017
finance.yahoo.com - May 22 at 5:23 PM |
 | INC Research Holdings Inc (INCR) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - May 19 at 11:06 PM |
| INC Research Holdings, Inc. :INCR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017
finance.yahoo.com - May 19 at 5:37 PM |
| INC Research, InVentiv reveal post-merger executive team
finance.yahoo.com - May 19 at 5:37 PM |
| INC Research Holdings Inc (INCR) Raised to Outperform at Robert W. Baird
www.americanbankingnews.com - May 14 at 9:12 AM |
| INC Research Holdings, Inc. – Value Analysis (NASDAQ:INCR) : May 12, 2017
finance.yahoo.com - May 12 at 6:35 PM |
| Short Interest in INC Research Holdings Inc (INCR) Expands By 4.7%
www.americanbankingnews.com - May 12 at 7:24 AM |
 | INC Research (INCR) to Merge with inVentiv Health
www.streetinsider.com - May 11 at 6:31 PM |
| INC Research Holdings, Inc. breached its 50 day moving average in a Bullish Manner : INCR-US : May 11, 2017
finance.yahoo.com - May 11 at 6:31 PM |
| INC Research Holdings, Inc.: Gathering momentum, can it sustain its performance?
finance.yahoo.com - May 11 at 6:31 PM |
| INC Research Holdings Inc (INCR) Stock Rating Reaffirmed by Jefferies Group LLC
www.americanbankingnews.com - May 11 at 10:36 AM |
| INC Research Reports First Quarter 2017 Results
finance.yahoo.com - May 11 at 4:24 AM |
| inVentiv Group Holdings, Inc. -- Moody's places inVentiv's ratings under review for upgrade after INC Research merger announcement
finance.yahoo.com - May 10 at 11:22 PM |
| Edited Transcript of INCR earnings conference call or presentation 10-May-17 12:00pm GMT
finance.yahoo.com - May 10 at 11:22 PM |
| INC Research Holdings, INC. -- Moody's places INC Research's ratings under review for downgrade after inVentiv merger announcement
finance.yahoo.com - May 10 at 6:21 PM |
| INC Research Holdings Inc (INCR) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - May 10 at 3:52 PM |
| INC Research tops Street 1Q forecasts
finance.yahoo.com - May 10 at 1:21 PM |
| Investor Network: INC Research Holdings, Inc. to Host Earnings Call
finance.yahoo.com - May 10 at 1:21 PM |
| [$$] INC Research, InVentiv Health to Combine
finance.yahoo.com - May 10 at 1:21 PM |
| INC Research Holdings Inc (INCR) Releases FY17 Earnings Guidance
www.americanbankingnews.com - May 10 at 9:22 AM |
| Medical Services Stock Q1 Earnings on May 10: CRL, XON, INCR
finance.yahoo.com - May 9 at 12:23 PM |
| INC Research Holdings Inc (INCR) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - May 6 at 12:36 AM |
| Zacks Investment Research Upgrades INC Research Holdings Inc (INCR) to Hold
www.americanbankingnews.com - May 6 at 12:33 AM |
 | INC Research recognized by CSO Magazine for Second Consecutive Year for Innovative Employee Cyber Security Training Program
globenewswire.com - May 4 at 11:08 PM |
| INC Research recognized by CSO Magazine for Second Consecutive Year for Innovative Employee Cyber Security Training Program
finance.yahoo.com - May 4 at 6:06 PM |
| Analysts Anticipate INC Research Holdings Inc (INCR) Will Post Quarterly Sales of $250.22 Million
www.americanbankingnews.com - May 4 at 12:00 PM |
| INC Research Holdings (INCR) Receives Coverage Optimism Rating of 0.15
www.americanbankingnews.com - May 3 at 10:34 AM |
| $0.55 EPS Expected for INC Research Holdings Inc (INCR) This Quarter
www.americanbankingnews.com - May 2 at 8:00 PM |
| Alistair Macdonald Sells 9,467 Shares of INC Research Holdings Inc (INCR) Stock
www.americanbankingnews.com - May 2 at 6:48 PM |
| INC Research Holdings (INCR) Given Daily Coverage Optimism Rating of 0.34
www.americanbankingnews.com - April 29 at 7:44 PM |
| Short Interest in INC Research Holdings Inc (INCR) Rises By 120.3%
www.americanbankingnews.com - April 27 at 7:13 AM |
| INC Research Holdings (INCR) Earns Media Sentiment Rating of 0.44
www.americanbankingnews.com - April 26 at 4:28 PM |
| INC Research is the First CRO to obtain IAOCR’s Silver Workforce Quality Accreditation Status
finance.yahoo.com - April 25 at 10:43 AM |
| INC Research Holdings Inc (INCR) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - April 24 at 10:34 PM |
| INC Research breaks ground on new headquarters in Morrisville
finance.yahoo.com - April 24 at 5:35 PM |
| INC Research Holdings (INCR) Getting Positive Press Coverage, Study Shows
www.americanbankingnews.com - April 23 at 6:37 PM |
| INC Research Holdings Inc (INCR) Earns "Buy" Rating from Jefferies Group LLC
www.americanbankingnews.com - April 21 at 6:36 PM |
| INC Research Schedules First Quarter 2017 Earnings Call for Wednesday, May 10 ...
globenewswire.com - April 21 at 10:40 AM |
| INC Research Holdings (INCR) Earning Somewhat Positive News Coverage, Report Shows
www.americanbankingnews.com - April 20 at 11:51 PM |
| INC Research Schedules First Quarter 2017 Earnings Call for Wednesday, May 10, 2017
finance.yahoo.com - April 20 at 6:00 PM |
| INC Research Holdings Inc (INCR) Upgraded to B- by TheStreet
www.americanbankingnews.com - April 19 at 9:25 PM |
| INC Research Holdings (INCR) Receives Daily Media Impact Rating of 0.06
www.americanbankingnews.com - April 17 at 3:53 PM |
| INC Research Holdings (INCR) Given Daily News Sentiment Rating of -0.13
www.americanbankingnews.com - April 13 at 12:44 PM |
| INC Research Bolsters Support for Vaccine Trials through Expanded Site and Patient Initiatives - GlobeNewswire (press release)
globenewswire.com - April 8 at 9:04 AM |
| INC Research Bolsters Support for Vaccine Trials through Expanded Site and Patient Initiatives
finance.yahoo.com - April 7 at 10:27 AM |
| Christopher L. Gaenzle Sells 4,733 Shares of INC Research Holdings Inc (INCR) Stock
www.americanbankingnews.com - April 4 at 4:57 PM |
| INC Research Ranked “Top CRO to Work With” Among Top 10 Global CROs for Third Consecutive Time in Biannual CenterWatch Survey
finance.yahoo.com - April 3 at 4:31 PM |
| INC Research Strengthens Real World & Late Phase and Global Consulting Capabilities with Key Leadership ... - GlobeNewswire (press release)
globenewswire.com - March 30 at 6:18 PM |
| INC Research Strengthens Real World & Late Phase and Global Consulting Capabilities with Key Leadership Appointments
finance.yahoo.com - March 30 at 6:18 PM |
| Catalyst Biosciences Announces Emergence from Key Patent Opposition Period Supporting Marzeptacog Alfa (activated), Catalyst’s Lead Clinical Program
finance.yahoo.com - March 30 at 6:18 PM |
INC Research Holdings (INCR) Chart for Tuesday, May, 23, 2017
